Speakers

Next Generation Dx Summit 2013 – Speaker List 

Chong H. Ahn, Ph.D., Mitchell P. Kartalia Chair and Professor, Microsystems and BioMEMS Laboratory, School of Electronics and Computing Systems, University of Cincinnati

Randy Allen, Ph.D., Manager, Corporate Relations, Clinton Health Access Initiative (CHAI)

Andrew J. Armstrong, M.D., Associate Professor, Medicine and Surgery, Duke Cancer Institute, Divisions of Medical Oncology and Urology, Duke University

J. Carl Barrett, Ph.D., Vice President, Translational Sciences Onc iMed, AstraZeneca

Keith F. Batchelder, M.D., CEO, Genomic Healthcare Strategies

John F. Beeler, Ph.D., Director, Theranostics & Business Development, bioMerieux

Chiara Bell, Founder and CEO, CareTicker

Kenneth J. Bloom, M.D., CMO, Clarient, Inc.

Aaron D. Bossler, M.D., Ph.D., Clinical Associate Professor, Director Molecular Pathology Laboratory and Molecular Genetic Pathology Fellowship Program, University of Iowa Hospitals and Clinics and Co-Chair, AMP Economic Affairs Committee

Roslyn A. Brandon, Ph.D., Co-Founder, President & CEO Immunexpress

Jeremy Bridge-Cook, Ph.D., Senior Vice President, Research & Development, Luminex

John P. Burke, M.D., Chief, Division of Clinical Epidemiology & Infectious Diseases, Intermountain Medical Center and LDS Hospital, & Professor of Internal Medicine at the University of Utah

Mitchell I. Burken, M.D., Medicare Medical Director, Novitas Solutions, Inc.

Scott Cameron, M.D., Ph.D., Oncology Director, Clinical Research Physician, Novartis Institutes for BioMedical Research, Inc.

Karen C. Carroll, M.D., Professor of Pathology and Medicine; Director, Division of Medical Microbiology, The Johns Hopkins University School of Medicine

Jeffrey Chalmers, Ph.D., Professor, Chemical and Biomolecular Engineering, Ohio State University

Charles Chiu, M.D., Ph.D., Assistant Professor, Departments of Laboratory Medicine and Medicine (Infectious Diseases), UCSF School of Medicine

Sailesh Chutani, Ph.D., CEO, Mobisante

Melina Cimler, Vice President, Quality & Regulatory Affairs, Illumina, Inc.

Franklin R. Cockerill, III, M.D., Deptartment of Laboratory Medicine and Pathology, Mayo Clinic

Christopher L. Corless, M.D., Ph.D., Professor, Pathology and Medical Director, Knight Cancer Institute, Oregon Health & Science University

Maureen Cronin, Ph.D., Executive Director, Strategic Information Management, Celgene

Seth D. Crosby, M.D., Director, Alliances and Partnerships, Department of Genetics, Washington University School of Medicine

William S. Dalton, M.D., Ph.D., CEO, M2Gen; Director, Personalized Medicine Institute, H. Lee Moffitt Cancer Center & Research Institute

Dwight Denham, MBA, Director, Clinical Research, Beckman Coulter, Inc.

Richard Ding, CEO, bioTheranostics

Robert Di Tullio, Vice President, Global Regulatory and Clinical Affairs, Alere

Nicholas Dracopoli, Ph.D., Vice President & Head, Oncology Biomarkers, Janssen R&D LLC

David Duffy, Ph.D., Vice President, Research, R&D, Quanterix

Kenneth Emancipator, M.D., Director, Companion Diagnostics, Merck

Andrew C. Fish, Executive Director, AdvaMedDx

Felix Frueh, Entrepreneur-in-Residence, Third Rock Ventures

Christine C. Ginocchio, Ph.D., MT (ASCP), Senior Medical Director and Chief, Division of Infectious Disease Diagnostics, Department of Pathology and Laboratory Medicine and Department of Molecular Medicine, Feinstein Institute for Medical Research, North Shore-LIJ Health System, Professor, Hofstra North Shore-LIJ School of Medicine, NY

Michael Fannon, President, BioIT Solutions, Former CIO, Human Genome Sciences

W. Florian Fricke, Assistant Professor, Microbiology & Immunology, Institute for Genome Sciences, University of Maryland School of Medicine

Edward Gamson, Partner, Healthcare Life Sciences & Pharmaceutical of Husch Blackwell Sanders, LLP

Walter Gilde, Business Development Manager, KMC Systems, Inc.

Harry Glorikian, Founder & Managing Partner, Scientia Advisors LLC

Joe Gray, Ph.D., Associate Director, Translational Research for the Knight Cancer Institute, Oregon Health & Science University (OHSU); Director, OHSU Center for Spatial Systems Biomedicine (OCSSB) and Gordon Moore Chair of Biomedical Engineering, OHSU School of Medicine

Emily J. Greenspan, Ph.D., Program Manager, Office of the Director, Center for Strategic Scientific Initiatives (CSSI), National Cancer Institute

Steven Gutman, M.D., Strategic Advisor, NA, Myraqa, Inc.

Amir Handzel, Ph.D., Associate Director, Translational and Clinical Sciences, OSI Pharma (Astellas)

Kevin M. Harter, President and CEO, Saladax Biomedical

Rob Havasy, Project Specialist and Operations Manager, Center for Connected Health, Partners HealthCare System, Inc

Randall T. Hayden, M.D., Director, Clinical and Molecular Microbiology, Member, Department of Pathology, St. Jude Children’s Research Hospital

Jeff Hester, Ph.D., Vice President, Research & Development, Viracor-IBT Laboratories

James Hicks, Ph.D., Research Professor, Genetics, Cold Spring Harbor Laboratory

Cristian Ionescu-Zanetti, Ph.D., CTO, Fluxion Biosciences

Filip Janku, M.D., Ph.D., Assistant Professor, Investigational Cancer Therapeutics, (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center

Elaine K. Jeter, M.D., J1 MolDx Medical Director, Palmetto GBA

Roger Klein, M.D., J.D., Department of Molecular Pathology, Cleveland Clinic Foundation

Gerald J. Kost, M.D., Ph.D., MS, Professor, Pathology and Laboratory Medicine; Director, Clinical Chemistry and Point-of-Care Testing; Faculty, Biomedical Engineering and Comparative Pathology, University of California, Davis

Shashikant Kulkarni, Ph.D., Head, Clinical Genomics, Washington University School of Medicine at St. Louis

Marc Ladanyi, M.D., William Ruane Chair in Molecular Oncology, Attending Pathologist, Molecular Diagnostics Service; Member, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center

Andrea Lauber, Ph.D., Global Head, Transactions for Clinical Biomarkers and Pharmacodiagnostics, Bristol-Myers Squibb

Nathan A. Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin

Debra G.B. Leonard, M.D., Ph.D., Professor and Chair, Department of Pathology, UVM College of Medicine, Physician Leader, Pathology and Laboratory Medicine, Fletcher Allen Health Care, UVM College of Medicine

Jack H. Lichy, M.D., Ph.D., Chief, Pathology & Laboratory Medicine, VA Medical Center, Washington, D.C.

Minetta C. Liu, M.D., Associate Professor, Oncology, Laboratory Medicine and Pathology, Mayo Clinic

Bert K. Lopansri, M.D. Division of Infectious Diseases and Clinical Epidemiology Intermountain Medical Center and LDS Hospital, Medical Director, UCR Clinical Microbiology Laboratory

Matthew Lorence, Ph.D., MBA., Senior Vice President, Marketing, Sales, and Business Development, TessArae, LLC

Dario Marchetti, Ph.D., Professor, Pathology & Immunology and Molecular & Cellular Biology; Director, CTC Core Facility, Baylor College of Medicine

Anita M. McClernon, MSc, Director of Laboratory Services, bioMONTR® Labs

John T. McDevitt, Brown Wiess Professor, Bioengineering & Chemistry, Rice University

Scott McKeown, Ph.D., Molecular Diagnostics Business Manager, Randox Laboratories Ltd.

Laura McMullan, Ph.D., Molecular Pathogenesis and Antiviral Section, Virus Special Pathogens Branch, Centers for Disease Control

Dan Mercola, M.D., Ph.D., Professor, Pathology and Laboratory Medicine; Director, Translational Cancer Biology University of California at Irvine

Keith Miller, CSO, UCL Cancer Institute, School of Life and Medical Sciences, University College London

Peter S. Miller, COO, Genomic Healthcare Strategies

Gordon Mills, M.D., Ph.D., Chairman, Department of Systems Biology, Chief, Section of Molecular Therapeutics; Professor of Medicine and Immunology; and Anne Rife Cox Chair in Gynecology, MD Anderson Cancer Center

David Miyamoto, M.D., Ph.D., Instructor, Radiation Oncology, Massachusetts General Hospital

Richard A. Montagna, Ph.D., Senior Vice President, Scientific Affairs, Rheonix, Inc.

James M. Musser, M.D., Ph.D., Fondren Distinguished Endowed Chair; Pathology and Genomic Medicine, The Methodist Hospital System; Dir., Ctr for Mol. and Translational, Human Infectious Diseases Research, The Methodist Hospital Research Institute

David M. Nanus, M.D., Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College - New York Presbyterian Hospital

Lee H. Newcomer, M.D., Senior Vice President, Oncology, United Healthcare

Michael Nohaile, Ph.D., Vice President, Corporate Strategy, Amgen, Inc.

Susan M. Novak-Weekley, Ph.D., D(ABMM) Director, Microbiology, Southern California Permanente Medical Group Regional Reference Laboratories

Jason Oberfest, Co-Founder and CEO, Mango Health

Sally Okun, RN, MMHS, Vice President, Advocacy, Policy & Patient Safety, PatientsLikeMe

Steven Michael Opal, M.D., Professor of Medicine, Infectious Disease Division, Brown Medical School

Gary Palmer, M.D., J.D., MBA, MPH, Senior Vice President, Medical Affairs and Commercial Development, Foundation Medicine

Jonathan Pan, Ph.D., Director, Oncology Companion Diagnostic and Disease Strategy, GlaxoSmithKline

William Pignato, Global Head, Regulatory Affairs, Novartis Oncology Companion Diagnostics

Victoria Pratt, Ph.D., FACMG, Chief Director, Molecular Genetics, Quest Diagnostics Nichols Institute

Lori Pressman, Independent Consultant

Ximei Qian, Ph.D., Assistant Professor, Biomedical Engineering, Emory University

Badri Rengarajan, M.D., Medical Director, Archimedes

Gavin P. Robertson, Ph.D., Professor, Pharmacology, Pathology, Dermatology and Surgery, Penn State University; Director, Penn State Melanoma Center, Penn State Melanoma Therapeutics Program, and Foreman Foundation Melanoma Research Laboratory

Mark Alexandre Rogers, M.D., Head, Near Patient Testing Unit, Novartis

Barrett J. Rollins, M.D., Ph.D., Linde Family Professor of Medicine, Harvard Medical School; CSO, Dana-Farber Cancer Institute

Jeffrey S. Ross, M.D., Medical Director, Foundation Medicine; Cyrus Strong Merrill Professor and Chair, Pathology and Laboratory Medicine, Albany Medical College

Jonathan Roy, Senior Director, Head,Commercial Diagnostics, GlaxoSmithKline

Hans Sauer, Ph.D., J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization

Mark Sausen, Ph.D., Associate Scientist , Personal Genome Diagnostics

Pietro Scalfaro, M.D., EMBA, CEO Spinomix SA

Howard I. Scher, M.D., Chief, Genitourinary Oncology Service, Sidney Kimmel Center for Urologic and Prostate Cancers, Memorial Sloan-Kettering Cancer Center

Uwe Scherf, M.Sc., Ph.D., Deputy Director, Division of Microbiology Devices, Office of In Vitro Diagnostics and Radiological Health (OIR), Center for Devices and Radiological Health, U.S. Food and Drug Administration

Cecilia Schott, Executive Business Development Director, Personalized Healthcare, AstraZeneca

Sushma Selvarajan, Head, Business Development & Strategy, Roche Molecular Systems

Premal Shah, Ph.D., Director, Business Development, Genomic Health, Inc.

Steve Shak, M.D., CMO, Genomic Health, Inc.

Adam J. Singer, M.D., Professor and Vice Chairman for Research, Department of Emergency Medicine, Stony Brook University

Denis Smirnov, Ph.D., Associate Scientific Director, Oncology Biomarkers, Janssen Pharmaceuticals

David B. Solit, M.D., Elizabeth & Felix Rohatyn Chair, Memorial Sloan Kettering Cancer Center

Dietrich Stephan, Ph.D., Founder & CEO, Silicon Valley Biosystems (SVBio)

Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.

Edith Szafer-Glusman, Ph.D., Senior Research Associate, Oncology Biomarker Development, Genentech

Patrick Tang, M.D., Ph.D., FRCPC, Program Head, Molecular Microbiology and Genomics, BC Centre for Disease Control - Public Health Microbiology and Reference Laboratory

Rich Thayer, Managing Partner, Halteres Associates, LLC; CEO, Catalysis Foundation for Health

Dirk van den Boom, Executive Vice President, R&D & CTO, Sequenom, Inc.

Sonny Vu, Ph.D., CEO, Misfit Wearables

Gene Walther, MBA, Deputy Director, Diagnostics, Discovery, Bill & Melinda Gates Foundation

Lihua Wang, Ph.D., Senior Scientist, PADIS, LHTP, Applied Developmental Directorate, SAIC-Frederick, National Cancer Institute

Karen E. Weck, M.D., Professor & Director, Molecular Genetics Laboratory, University of North Carolina School of Medicine

P. Mickey Williams, Ph.D., Director, Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research

Penny Wilson, Ph.D., Lead Specialist, Detection and Identification of Infectious Agents, Technology Strategy Board

Donna M. Wolk, MHA, Ph.D., D(ABMM), System Director, Clinical Microbiology, Geisinger Health System, Department of Laboratory Medicine